Lawsuit Accuses ChatGPT of Designing Fatal Drug Tapering
Announcement from the federal judiciary
Headline as published by California Courts Newsroom (undated in the feed); collected by the wire Oct 29, 2026, 5:45 PM ET.
Lawsuit Accuses ChatGPT of Designing Fatal Drug TaperingMartin.Novitski Thu, 10/29/2026 - 10:55 NewsLink The parents of a woman who was found dead in her Seattle apartment have filed a complaint in San Francisco Superior Court against the Bay Area-based OpenAI and its CEO Sam Altman, accusing the defendants of engaging in the unauthorized practice of medicine and producing a defective product based on allegations that ChatGPT encouraged their daughter to taper off a life-saving epilepsy medication, causing her demise.
Coverage
Topics
- Product liabilityMatched on
defective product
- Lawsuits and filingsMatched on
Lawsuit
- Legal technology and AIMatched on
ChatGPT
Explore the named firms, organizations and MDL dockets above. Sources and method